SPOTLIGHT -
Dr. Feret is clinical assistant professor, University of Rhode Island college of Pharmacy, Kingston, RI.
Fampridine-SR: A potassium-channel blocker for the improvement of walking ability in patients with MS
Fampridine-SR is a sustained-release oral medication that is pending FDA approval for the symptomatic treatment of multiple sclerosis (MS).